Cybin Inc. Common Stock
(HELP - NASDAQ)
12,22 USD
📋 Profilo Aziendale

Cybin Inc. functions as a biopharmaceutical company currently in its clinical development phase, concentrating on the advancement of novel therapeutic agents derived from psychedelic compounds.

|